In a patient with persistent irritable bowel syndrome symptoms and frequent food intolerances who shows low‑grade inflammation on colonoscopy, how should this finding be evaluated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Low-Grade Inflammation on Colonoscopy in IBS Requires Biopsy to Rule Out Microscopic Colitis

When a patient with persistent IBS symptoms and food intolerances shows low-grade inflammation on colonoscopy, you must obtain biopsies to exclude microscopic colitis, as this is the only way to make this diagnosis and it fundamentally changes management. 1

Why This Matters

Low-grade inflammation visible on colonoscopy in an IBS patient is not typical IBS and demands investigation. True IBS should show normal endoscopic findings. The presence of visible inflammation, even if subtle, suggests an organic pathology that requires histological confirmation.

The Microscopic Colitis Problem

Microscopic colitis (MC) is a diagnostic chameleon that mimics IBS-D perfectly:

  • Prevalence: 10-11% of patients initially diagnosed with IBS-D actually have microscopic colitis 1, 2
  • Symptom overlap: 33.4% of MC patients meet Rome IV criteria for IBS 1
  • Age consideration: Most common over age 60, but can occur at any age 1
  • Critical point: Colonoscopy and biopsy remain the only way to diagnose microscopic colitis 1

Evaluation Algorithm

Step 1: Obtain Multiple Biopsies

  • Take biopsies from multiple colonic segments, even if mucosa appears normal
  • MC can be patchy and may not correlate with visible inflammation
  • This is non-negotiable when any inflammation is present 1

Step 2: Measure Fecal Calprotectin

  • Calprotectin levels are often elevated in MC (can range 49-213 μg/g) 2
  • 40% of MC patients have calprotectin >100 μg/g 2
  • However, 60% have levels <100 μg/g, so normal calprotectin does not exclude MC 2
  • Higher levels correlate with degree of microscopic inflammation 2

Step 3: Consider Age and Risk Factors

  • Patients >50 years with diarrhea-predominant symptoms warrant colonoscopy with biopsy regardless 1
  • Patients <50 years may not need routine colonoscopy unless inflammation is visible or alarm features present 1

Management Implications

If biopsies confirm microscopic colitis:

  • This is NOT IBS—it requires specific MC treatment (budesonide is first-line)
  • Standard IBS therapies will fail 2
  • Delay in diagnosis leads to ongoing suffering and unnecessary treatment escalation 2

If biopsies show non-specific inflammation:

  • Consider post-infectious IBS mechanisms 3
  • Low-grade inflammation can be part of IBS pathophysiology in some patients 3
  • May respond to anti-inflammatory approaches targeting gut immune dysregulation 3

If biopsies are normal despite visible inflammation:

  • Re-evaluate for subtle IBD
  • Consider bile acid diarrhea (SeHCAT scan if available) 4
  • Assess for celiac disease if not already done 4

Common Pitfalls to Avoid

  1. Assuming visible inflammation is "just IBS"—it's not; IBS should have normal endoscopy
  2. Skipping biopsies when inflammation is present—you will miss microscopic colitis
  3. Relying solely on calprotectin—60% of MC patients have normal levels 2
  4. Treating empirically as IBS without tissue diagnosis—leads to treatment failure and patient frustration 2

The Food Intolerance Connection

Food intolerances in this context may reflect:

  • Underlying MC with secondary malabsorption
  • Bile acid diarrhea (common in both IBS and MC)
  • True IBS with visceral hypersensitivity
  • Small intestinal bacterial overgrowth secondary to inflammation

Do not attribute symptoms solely to food intolerances without excluding organic pathology first.

References

2
Research

Microscopic Colitis: A Diagnostic Challenge in Patients with Irritable Bowel Syndrome.

Journal of gastrointestinal and liver diseases : JGLD, 2023

4
Research

Rational investigations in irritable bowel syndrome.

Frontline gastroenterology, 2020

Related Questions

For an adult with diarrhea-predominant irritable bowel syndrome (IBS-D), which over-the-counter medication provides the greatest benefit?
What are the differences between ulcer pain and irritable bowel syndrome (IBS) pain?
In a 34-year-old man with eight months of crampy abdominal pain and bloating, normal laboratory studies, no weight loss, and prior ineffective treatment for irritable bowel syndrome, what is the most likely diagnosis: microscopic colitis, irritable bowel syndrome, or celiac disease?
Can epigastric pain syndrome (EPS) occur in patients with irritable bowel syndrome (IBS)?
What evaluations should be performed for an 8-year-old child with chronic constipation since age 4, intermittent week-long stool withholding, and a recent episode of severe abdominal pain that resolved with medication?
Is pleocytosis in cerebrospinal fluid more common in macrophage activation syndrome (MAS) or toxic shock syndrome (TSS)?
What investigations are indicated for a non‑ischemic stroke in a 25‑year‑old woman?
Can a sodium-glucose cotransporter-2 (SGLT2) inhibitor be started in a diabetic patient with pyuria and possible vulvar candidiasis who is afebrile?
What investigations are indicated for a 25-year-old patient with isolated central retinal vein occlusion?
What adverse effects can result from drinking green tea?
In a patient with chronic kidney disease and fluid overload, should the IV fluid be plain lactated Ringer’s solution or plain normal saline (0.9% NaCl)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.